<SEC-DOCUMENT>0001144204-16-079720.txt : 20160209
<SEC-HEADER>0001144204-16-079720.hdr.sgml : 20160209
<ACCEPTANCE-DATETIME>20160209073014
ACCESSION NUMBER:		0001144204-16-079720
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20160209
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160209
DATE AS OF CHANGE:		20160209

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STAAR SURGICAL CO
		CENTRAL INDEX KEY:			0000718937
		STANDARD INDUSTRIAL CLASSIFICATION:	OPHTHALMIC GOODS [3851]
		IRS NUMBER:				953797439
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-11634
		FILM NUMBER:		161397233

	BUSINESS ADDRESS:	
		STREET 1:		1911 WALKER AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016
		BUSINESS PHONE:		6263037902

	MAIL ADDRESS:	
		STREET 1:		1911 WALKER AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STAAR SURGICAL COMPANY
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v430858_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;UNITED STATES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">WASHINGTON, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">FORM 8-K</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">CURRENT REPORT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Pursuant to Section&nbsp;13 or 15(d) of
the Securities Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 44%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date of Report (Date of Earliest Event Reported):</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 9, 2016</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 18pt">STAAR Surgical
Company</FONT><BR>
<FONT STYLE="font-size: 10pt">__________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%">&nbsp;</TD>
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="width: 33%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delaware</U></FONT></TD>
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>0-11634</U></FONT></TD>
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>95-3797439</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of incorporation)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">File Number)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>1911 Walker Ave, Monrovia, California</U></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>91016</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of principal executive offices)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 46%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 44%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&rsquo;s telephone number, including area code:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">626-303-7902</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Not Applicable</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">______________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Former name or former address, if changed
since last report</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.4pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.4pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.4pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8.4pt; text-indent: 0.5in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><B>Item
7.01 Regulation FD Disclosure.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 4.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 1in; text-align: justify">STAAR
Surgical Company issued a press release regarding a cooperation agreement with a customer, Memira Holding
AB-SE. A copy of the press release is furnished as Exhibit 99.1 to this Report, and is incorporated herein by this
reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 4.5pt; text-align: justify; text-indent: 63pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information furnished herewith pursuant to Item 7.01 of this Current Report, including Exhibit 99.1, shall not be deemed to be
&ldquo;filed&rdquo; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;),
or otherwise subject to the liabilities of that section. The information in Item 7.01 of this Current Report shall not be incorporated
by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the
date of this Current Report, regardless of any general incorporation language in the filing</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 4.5pt; text-align: justify; text-indent: 63pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
9.01</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial Statements and Exhibits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.3pt 0pt 4.5pt; text-align: justify; text-indent: 63pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 1in; text-indent: 0in; text-align: justify">(d)
Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 1in; text-indent: 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 1in; text-indent: 0in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 15%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>Exhibit No.</U></B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 83%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>Description</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="text-align: center">99.1</TD>
    <TD>&nbsp;</TD>
    <TD>Press Release dated February 9, 2016.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 1in; text-indent: 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 1in; text-indent: 0in; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 1in; text-indent: 0in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt">Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-left: 4.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STAAR Surgical Company&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; padding-left: 4.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 9, 2016</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 76%; text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>/s/ Caren Mason</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Caren Mason</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v430858_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 48.75pt; width: 117pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>STAAR Surgical Company and Memira Holding
Announce Cooperation Agreement for Memira&rsquo;s Eye Clinics throughout Scandinavia</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>MONROVIA, CA, February 9, 2016</B>---STAAR Surgical Company
(NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, and Memira
Holding, Sweden, today announced they have entered into an agreement effective January 1, 2016, to provide STAAR&rsquo;s phakic
intraocular lenses (ICL) as a primary and premium option for refractive eye treatment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;As the largest refractive eye surgery provider in Scandinavia
with close to 50 clinics and having completed over 400,000 refractive surgery procedures over the last 25 years; we are very pleased
to join with STAAR to provide our patients seeking to reduce or correct myopia, hyperopia and astigmatism with an outstanding vision
care treatment in the CentraFLOW&reg; ICL. It is our intention to partner with STAAR in building a clinical data repository, participating
in new product testing, providing excellent training and certification for our surgeons, placing the ICL as a primary vision treatment
and delivering value pricing for our patients. Our plans are to continue to expand our vision treatment services and we believe
STAAR will be an excellent partner to work with us to achieve our objectives, said Michael Lagerb&auml;ck, COO of Memira.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;STAAR is pleased to have entered
into a strategic cooperation agreement with Memira where the CentraFLOW Visian implantable Collamer&reg; lens will be positioned
as a primary and premium vision correction solution for their patients. In partnership with our distributor Alyko Medical, we have
committed to provide Memira with close cooperation including technical, marketing, clinical and educational programs to drive the
further growth of the ICL. STAAR considers cooperation and strategic agreements as fundamental to its transformational goal to
closely align with its customers to create an outstanding vision care experience and outcome for patients with essential clinical
validation as a core tenet,&rdquo; said Caren Mason, President &amp; CEO of STAAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I><U>About STAAR Surgical</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">STAAR, which has been dedicated solely to ophthalmic surgery
for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems.
These lenses are intended to provide visual freedom for patients lessening or eliminating the reliance on glasses or contact lenses.
All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR&rsquo;s lens used in
refractive surgery is called an Implantable Collamer&reg; Lens or &ldquo;ICL&rdquo;. More than 550,000 Visian ICLs have been implanted
to date. To learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 employees and markets lenses in over
60 countries. Headquartered in Monrovia, CA, the company operates manufacturing facilities in Aliso Viejo, CA and Monrovia, CA.
For more information, please visit the Company&rsquo;s website at www.staar.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I><U>Safe Harbor</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All statements in this press release that are not statements
of historical fact are forward-looking statements, including statements about any of the following: statements regarding proposed
prospective products current or future and any statements of assumptions underlying any of the foregoing. Important factors that
could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the Company&rsquo;s
Annual Report on Form 10-K for the year ended January 2, 2015, under the caption &ldquo;Risk Factors&rdquo;, which is on file with
the Securities and Exchange Commission and available in the &ldquo;Investor Information&rdquo; section of the company&rsquo;s website
under the heading &ldquo;SEC Filings.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">These statements are based on expectations and assumptions as
of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ
materially from those described in the forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 25%">CONTACT:</TD>
    <TD STYLE="width: 30%"><B>Investors</B></TD>
    <TD STYLE="width: 45%"><B>Media</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>EVC Group</TD>
    <TD>EVC Group</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Brian Moore, 310-579-6199</TD>
    <TD>Dave
Schemelia, 646-445-4800</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Doug Sherk, 415-652-9100&#9;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "5 68# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W2>XEM?F=
M \7=AQCZ_P"0/>EBU"VED$7F;)3R(Y/E8_3U'N,BK59%]I),;&T2*1"<M:3#
M,;'U7^X?<<>W>D[K89KT5REI-<-*T.F7SP7,?WM.U#YL?[K=<?0FISXJ>PD$
M6LZ=/:,>!(GSQG\?_P!=+G74?*SI**J6>J6&H+FTNXI?96Y'X=:MU1(4444
M%%%% !5=91_:,D.>?*5OU858K%CN@?&<UMGI9*?QWG_&DW8:-JBBBF(****
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M[:(3=O4JZ7I-II-OY5LGS-R\C<LY]2:O445JE8@**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!&570HZ
MAE88((R"*\[\4>$FL"U]IZEK;.7C'6/W'M_*O1:",C!Z5,HJ2U&I-'G6@>-9
MK0K;:D6F@Z"7JZ?7U'ZUZ!;W$-U D\$BR1.,JRG(-<#XL\*_9"^H:?'_ *.>
M98A_RS]Q[?R^G3"T77KS1)]T#;X2?GA8_*W^!]ZR4W!VD:.*DKH]=EABGC,<
ML:2(>JNN0:P;WP7H]YEDA:W<]X6P/R.16CI&LVFLVOG6S_,/OQM]Y#[_ .-:
M%:V4D9W://KOX>W29-I>12#^[(I4_IFMZ7P](W@Q=)7;]H5 V<\;\[CS^8KH
MZ*2IQ6P^9LX"T^'EPV#>7L:#NL2EOU.*Z"R\':-9$,8#<./XICN_3I^E;]%"
MIQ70')L;'&D2!(T5$'15& *BN[RWL;9KBYE6*)>K,?\ .35+6M>M-$M]\S;Y
MF'[N%3\S?X#WKR_5M:O-9N?-N9/E'W(U^Z@]O\:4ZBCH$8MFSK_C*XU'=;V.
MZWM>A;.'?Z^@]JN^%O"'G!+_ %./]W]Z* _Q>[>WM3_"7A3<(]2U"/CAH86'
M7T8_T%=W4P@Y>](J4K:(    !@#M1116QF%%%95QK#-J+Z;IT(N;R-0TQ9]L
M<(/3<V#R>R@9^G6FDV!JT5F>3KF"?MVG@]A]C?'TSYOZUA:OXUN/#TL5MJND
M2>=,P6"6WD#0R\@'D\J>>F#_ %JE!RT0F[;G845!?7/V/3[FZV;_ "8FDVYQ
MNP"<9_"N-\.>.M7\3LYL/#:K"AP\\M[M0'TSY9)/T%$8.2;0-I:'<T5S7B+Q
M'J/AO1WU*YTRUEC1E4K'>-GDX[QU6\+>+[[Q79SW-KI5O"L,GED2WAR3C/:/
MWH]G+EYN@<RO8ZZBN.\1^+M:\-0BXNO#L<UKG!G@O2RJ>V<Q@C^5;WA[5_[>
MT&TU/R/(^T*3Y>_=MPQ'7 ST]*'"2CS= 4E>QIT45R'B[QNGAG6-*LML;K</
MNN2V<QQ9QD<]<Y_[YI1BY.R!M+5G7T4 @@$'(-%2,**** "BN0M/&\=S\0+C
MP[MC\A$*QRC[S2@98=<8QD?45U]5*+CN)-/8***J3R:BLI%O:VLD?9I+AD)_
M (?YU*&6Z*\\TKXFSZOXACT:+18TF>1D#M=G:"H)/\&>QKK;JXUZ"-Y(+"QN
ML#(C%RT;'V!*$?RK25.479DJ2>QK45R.@?$#3M8U Z9<P2Z=J(8IY$YX+#JH
M;U]B!73W4SPP@QJ#(S!%W=,D]34RA*+LQII[$]%<Q8^);B:Q^V/ KQ_("JG:
M0S('ZGT!Z8[CDT4_9R#F1T]%%%0,**** "BBB@!" RE6 ((P0>]>:>+?#9TN
M<WEJG^AR'D#_ )9MZ?3T_*O3*ANH(;FUEAN%5H74APW3%1.*DBHRLSQJQOKG
M3KI+FUE,<B]QT(]#ZBO4?#_B*WURWP,1W2#]Y%G]1ZBO/(]"DO=3N(;"59+.
M)R#=.=J*OJ374V.J>'/"\!B@F:[N#_K)(ER6_'ICV!K&FW'?8N=F=I145M<)
M=6L5Q&<I*@=?H1FI:Z3(*P/$GB:'1(O*BQ)>.,JG91ZG_"M>^O(M/L9KN;/E
MQ+N('4^PKD=1O/#OBJ(!KG[)> 8CDE7;^!/0C\:B;LK+<J*[G#W5U/>W#W%S
M*TDKG)9JZGP?X:%\ZZC>IFV0_NT(_P!81W^@_6LJ'0S:ZW;VNJN(;:1O]<#E
M''LWO^E>KQ1QQ1)'$H6-5 55Z =JRIPN[LN<K*R'T445T&04444 (QVJ3Z#-
M>=?"O7(;^/58;B4?VC-=-<L&/+JP X]<$'Z9%>C5XWXJ^&^JZ?J<FI^'M\L)
M<R".)MLL))_A]1Z8Y_G6]%1DG&3M<B=U9H]DK(\2Z,FNZ,]J54RJZRPLW\+J
M<C\^1^->06GQ%\6Z%*+>_P S;>L=["0X_'@_GFNPTCXO:7=.D6IVDMDQX\Q#
MYB#Z]"/R--X>I!W6HN>+T9WFIP/=:3>6\0!DE@=%R<#)4@5#H>DPZ)HMKIT"
M@+#& Q'\3=V_$Y-789HKB%)H9%DB=0R.AR&![@T^L+NUB[=3B_BG_P B+<?]
M=8__ $*LOX-_\B_J'_7U_P"R"M3XI_\ (BW'_76/_P!"K+^#?_(OZA_U]?\
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MKGTFN9/$M]9OJ$T=O%"LB !/E)Z\E:&[ D=!16-X?U"YOA>I,XFC@G,<5P%
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MU<V.A2W5K.T4L97! !SE@.<CWK8C4I&JEV<@?>;&3^5%];#L.HHHIB"BBB@
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K "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
